BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27903977)

  • 21. Connexin 43-mediated bystander effect in two rat glioma cell models.
    Sanson M; Marcaud V; Robin E; Valéry C; Sturtz F; Zalc B
    Cancer Gene Ther; 2002 Feb; 9(2):149-55. PubMed ID: 11857032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of ATP-sensitive potassium channels increases HSV-tk/GCV bystander effect in U373 human glioma cells by enhancing gap junctional intercellular communication.
    Paíno T; Gangoso E; Medina JM; Tabernero A
    Neuropharmacology; 2010 Nov; 59(6):480-91. PubMed ID: 20603136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions.
    Touraine RL; Vahanian N; Ramsey WJ; Blaese RM
    Hum Gene Ther; 1998 Nov; 9(16):2385-91. PubMed ID: 9829537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic inhibitory effect of resveratrol and TK/GCV therapy on melanoma cells.
    Chen Y; Li H; Zhang G; Wu Y; Xiao J; Liu J; Qiu P; Liu X; Sun L; Du B; Tan Y
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1489-1499. PubMed ID: 32246216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Connexin 43-enhanced suicide gene therapy using herpesviral vectors.
    Marconi P; Tamura M; Moriuchi S; Krisky DM; Niranjan A; Goins WF; Cohen JB; Glorioso JC
    Mol Ther; 2000 Jan; 1(1):71-81. PubMed ID: 10933914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Synergistic effect of all-trans retinoic acid and herpes simplex virus thymidine kinase gene on glioma].
    Zhang XF; Ren ZY; Fang FD; Zuo J; Su CB; Wang RZ; Ma WB
    Ai Zheng; 2002 May; 21(5):473-9. PubMed ID: 12452035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
    LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
    Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bystander effect in suicide gene therapy is directly proportional to the degree of gap junctional intercellular communication in esophageal cancer.
    Matono S; Tanaka T; Sueyoshi S; Yamana H; Fujita H; Shirouzu K
    Int J Oncol; 2003 Nov; 23(5):1309-15. PubMed ID: 14532970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells.
    Yang L; Chiang Y; Lenz HJ; Danenberg KD; Spears CP; Gordon EM; Anderson WF; Parekh D
    Hum Gene Ther; 1998 Mar; 9(5):719-28. PubMed ID: 9551619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells.
    Huang Q; Liu XZ; Kang CS; Wang GX; Zhong Y; Pu PY
    Cancer Gene Ther; 2010 Mar; 17(3):192-202. PubMed ID: 19851353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATRA enhances bystander effect of suicide gene therapy in the treatment of prostate cancer.
    Chen W; Yan C; Hou J; Pu J; Ouyang J; Wen D
    Urol Oncol; 2008; 26(4):397-405. PubMed ID: 18367126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery.
    Tanaka M; Fraizer GC; De La Cerda J; Cristiano RJ; Liebert M; Grossman HB
    Gene Ther; 2001 Jan; 8(2):139-48. PubMed ID: 11313783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATRA enhances the bystander effect of suicide gene therapy driven by the specific promoter LEP 503 in human lens epithelial cells.
    Yang J; Liu TJ; Jiang YX; Lu Y
    Mol Vis; 2012; 18():2053-66. PubMed ID: 22876133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells.
    Matuskova M; Hlubinova K; Pastorakova A; Hunakova L; Altanerova V; Altaner C; Kucerova L
    Cancer Lett; 2010 Apr; 290(1):58-67. PubMed ID: 19765892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E-cadherin contributes to the bystander effect of TK/GCV suicide therapy and enhances its antitumoral activity in pancreatic cancer models.
    Garcia-Rodríguez L; Abate-Daga D; Rojas A; González JR; Fillat C
    Gene Ther; 2011 Jan; 18(1):73-81. PubMed ID: 20720574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Connexin over-expression differentially suppresses glioma growth and contributes to the bystander effect following HSV-thymidine kinase gene therapy.
    Jimenez T; Fox WP; Naus CC; Galipeau J; Belliveau DJ
    Cell Commun Adhes; 2006; 13(1-2):79-92. PubMed ID: 16613782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The mechanism of bystander effect in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy].
    Zhang L; Liu T; Cui Q; Gao J
    Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):440-4. PubMed ID: 11869559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.
    Ryu CH; Park KY; Kim SM; Jeong CH; Woo JS; Hou Y; Jeun SS
    Biochem Biophys Res Commun; 2012 May; 421(3):585-90. PubMed ID: 22525671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
    Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Replication-competent, oncolytic herpes simplex virus type 1 mutants induce a bystander effect following ganciclovir treatment.
    Luo C; Mori I; Goshima F; Ushijima Y; Nawa A; Kimura H; Nishiyama Y
    J Gene Med; 2007 Oct; 9(10):875-83. PubMed ID: 17685493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.